Clinical Trial Update: NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of NC-6004 (Nanoplatin) in combination with Gemcitabine for locally advanced and metastatic pancreatic cancer has completed in Asia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nanoplatin (NC-6004) (NC-6004)

Snippet

Sponsor: NanoCarrier Co., Ltd. | Conditions: Locally Advanced and Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED